Beta Bionics, Inc.
General ticker "BBNX" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $676.7M (TTM average)
Beta Bionics, Inc. follows the US Stock Market performance with the rate: 55.5%.
Estimated limits based on current volatility of 2.7%: low 28.06$, high 29.60$
Factors to consider:
- Total employees count: 800 as of 2024
Short-term BBNX quotes
Long-term BBNX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.18MM | $11.99MM | $65.12MM |
| Operating Expenses | $66.02MM | $47.84MM | $110.38MM |
| Operating Income | $-65.84MM | $-35.85MM | $-45.25MM |
| Non-Operating Income | $1.09MM | $-8.25MM | $-9.51MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $31.43MM | $17.94MM | $26.18MM |
| Income(Loss) | $-64.75MM | $-44.10MM | $-54.76MM |
| Profit(Loss)* | $-64.75MM | $-44.10MM | $-54.76MM |
| Stockholders Equity | $13.00MM | $58.61MM | $76.01MM |
| Inventory | $0.00MM | $1.25MM | $13.32MM |
| Assets | $35.53MM | $110.04MM | $149.65MM |
| Operating Cash Flow | $-60.21MM | $-32.45MM | $-48.27MM |
| Capital expenditure | $0.77MM | $0.40MM | $3.40MM |
| Investing Cash Flow | $-0.77MM | $-69.69MM | $-3.48MM |
| Financing Cash Flow | $56.78MM | $101.03MM | $55.62MM |
| Earnings Per Share** | $-12.96 | $-8.31 | $-8.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.